Allero Therapeutics is a newly created biotech start-up whose co-founders are based in four of the major European biotech clusters. Our objective is to develop next generation safe immunotherapies for immune mediated disorders.
Immune mediated disorders arise when our immune system is out of balance and attacks our own tissues as in autoimmune diseases or overreact to otherwise innocous external agents such as pollens or house dust mites as in allergic disorders.
Current treatments of immune mediated disorders remain unsatisfactory as they either do not treat the underlying causes and have significant immuno suppressive side effects (e.g. for autoimmune disease) or efficacy and compliance is not great as it requires lengthy multi-year and daily treatment (e.g. for allergic disorders).

We are currently seeking best-in-class collaboration partners for our publications listed in the tab Opportunities. We want to invite you to cooperate with us, so please repond to any of the opportunities by submitting one or more proposals. Our team will directly evaluate them and get back to you with a response. Please provide as much detailed non-confidential information as possible to facilitate the engagement process.